Advances and prospects of drug clinical research in colorectal cancer in 2022
Advances and prospects of drug clinical research in colorectal cancer in 2022
About this item
Full title
Author / Creator
Su, Dan , Liu, Chao , Cui, Jie , Tang, Jiebing , Ruan, Yuli and Zhang, Yanqiao
Publisher
England: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
England: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Colorectal cancer (CRC) is the third most common cancer and the second leading cause of cancer death worldwide. Clinical research results have provided more treatment opportunities for CRC patients, showing that an optimal combination of existing drugs and new drugs is needed to mitigate the burden of this disease. In this review, we have summarize...
Alternative Titles
Full title
Advances and prospects of drug clinical research in colorectal cancer in 2022
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_6198ec32185942ad9c7671f592e97789
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6198ec32185942ad9c7671f592e97789
Other Identifiers
ISSN
2770-9183,2770-9191
E-ISSN
2770-9183
DOI
10.1002/cai2.62
